SHR3680
Not Tagged
['prostate']
#asco22 improved survival outcomes under shr3680 vs bicalutamide + adt in patients with high-volume metastatic hormone-sensitive #prostatecancer 
Director, @danaFarber_GU & International Strategic Initiatives @DanaFarber. Kohlberg Prof. of Medicine @Harvardmed. @PanMass rider. #SoccerIsLife. Views Mine.